Dilon Technologies Inc.

Dilon Technologies Inc. is a medical device company located in Newport News, Virginia, founded in 1997. The company specializes in women's healthcare and biosurgery, developing and marketing innovative medical devices aimed at improving patient outcomes, particularly in breast cancer diagnosis and surgical treatment. Dilon's product portfolio includes the Navigator® Gamma Probe System, which is used for radio-guided lymphatic mapping and tumor localization during cancer surgeries. The MarginProbe® technology allows for real-time margin assessment during breast cancer surgery. Other products include the CoPilot VL+ Video Laryngoscope for airway management, the HEMOBLAST® Bellows for surgical bleeding control, and the TrueView 200 Pro for identifying tumor lesions in resected tissue. Dilon also offers a sterilizable version of its gamma probe to minimize cross-contamination risks. The company serves a global market, distributing its products in 76 countries, including Canada, Japan, Australia, and various regions in Europe and Latin America. Dilon Technologies aims to meet the evolving needs of the healthcare industry with its specialized medical technologies.

• Employees 89
• Founded 2007
• Annual Revenue $11000000
• Total Funding $39399500